• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏动脉瘤治疗的单中心经验

Single-Center Experience in the Treatment of Visceral Artery Aneurysms.

作者信息

Martinelli Ombretta, Giglio Alessandra, Irace Luigi, Di Girolamo Alessia, Gossetti Bruno, Gattuso Roberto

机构信息

Department of Vascular Surgery, Policlinico Umberto I°, "Sapienza" University, Rome, Italy.

Department of Vascular Surgery, Policlinico Umberto I°, "Sapienza" University, Rome, Italy.

出版信息

Ann Vasc Surg. 2019 Oct;60:447-454. doi: 10.1016/j.avsg.2019.01.010. Epub 2019 Apr 19.

DOI:10.1016/j.avsg.2019.01.010
PMID:31009733
Abstract

BACKGROUND

Visceral artery aneurysms (VAAs), although rare, represent a life-threatening disease with high mortality rates. With the more frequent use of diagnostic tests, there has been an incidental detection of these lesions which are mostly asymptomatic. It follows that surgeons are increasingly called to decide on the most appropriate management of VAAs between an open surgical or endovascular approach and among the different endovascular options currently available. The aim of this retrospective study was to evaluate the results of open surgery and interventional endovascular strategies of visceral artery aneurysms with respect to technical success, therapy-associated complications, and postinterventional follow-up in the elective and emergency situation.

METHODS

From January 1992 to January 2017, 125 open surgical or endovascular interventions for VAA were performed at our institution. Once the VAA was diagnosed and the indication for treatment was assessed, the preoperative diagnostic work-up consisted of contrast computed tomography (CT) or magnetic resonance imaging (MRI) and, in some patients, digital subtraction angiography. Follow-up included clinical and duplex ultrasound scan (DUS) and contrast-enhanced ultrasound to assess the treated vessel patency and organ perfusion after 1, 6, and 12 months, and yearly thereafter. CT or MRI controls were also performed at 1 year of follow-up and only when DUS was not diagnostic or showed a complication thereafter. After the first 5 years of follow-up, the status of the patient was obtained by a structured telephone survey.

RESULTS

The treatment option was endovascular in 56 of 125 cases (44.8%). Technical success was 98.3%. In one case, the procedure was interrupted for the extensive dissection of the afferent vessel. Twenty-six patients were treated by coil embolization while 29 with covered stenting. The endovascular approach was in emergency in two cases (3.6%). In the endovascular group, mortality was nil. Complications occurred in 5 cases (8.9%): 1 subacute intestinal ischemia caused by superior mesenteric artery dissection, 2 aneurysm reperfusion, 1 stent thrombosis, and 1 massive splenic hematoma. In 69 (55.2%) cases, surgical treatment was preferred, with 24 VAA resections and 45 arterial reconstructions. In 20 cases (29%), open surgery was performed in emergency conditions. In the surgical group, 8 emergency patients (40%) died intraoperatively. The mortality after elective surgical interventions was nil. Complications after surgery were 4 graft late thrombosis (5.8%): asymptomatic in three cases and requiring splenectomy in one.

CONCLUSIONS

There is no overall consensus regarding the indications for treatment of VAA. Currently in emergent setting, the endovascular approach should be considered as the first choice because of its reduced invasiveness, faster way to access and bleeding control; this accounts for the lower morality of the interventional therapy than open surgery. Endovascular approach is effective for elective repair of VAAs, but procedure-related complications may occur in a not negligible number of patients. Given comparable mortality rates and low procedure-related complication rate, surgical approach still has space in the elective management of VAAs, especially for aneurysms unsuitable or challenging for the endovascular option in patients with low surgical risk. The size, location, and morphology of VAAs, systemic or local comorbidities, and specific anatomical situations such as previous abdominal surgery should dictate treatment choice.

摘要

背景

内脏动脉瘤(VAA)虽罕见,但却是一种死亡率很高的危及生命的疾病。随着诊断检查的更频繁使用,这些大多无症状的病变被偶然发现。因此,外科医生越来越多地被要求在开放手术或血管内介入方法以及目前可用的不同血管内选择之间,决定对VAA最合适的治疗方案。这项回顾性研究的目的是评估内脏动脉瘤开放手术和介入性血管内治疗策略在技术成功率、治疗相关并发症以及择期和急诊情况下介入后随访方面的结果。

方法

1992年1月至2017年1月,我们机构对125例VAA进行了开放手术或血管内介入治疗。一旦诊断出VAA并评估了治疗指征,术前诊断检查包括对比计算机断层扫描(CT)或磁共振成像(MRI),在一些患者中还包括数字减影血管造影。随访包括临床检查和双功超声扫描(DUS)以及对比增强超声,以在1、6和12个月以及此后每年评估治疗后血管的通畅情况和器官灌注。在随访1年时以及仅当DUS无法诊断或此后显示有并发症时,也进行CT或MRI检查。在随访的前5年之后,通过结构化电话调查获得患者的状况。

结果

125例病例中有56例(44.8%)选择血管内治疗。技术成功率为98.3%。1例因对输入血管进行广泛解剖而中断手术。26例患者接受了弹簧圈栓塞治疗,29例接受了覆膜支架置入术。血管内介入治疗有2例(3.6%)用于急诊情况。在血管内治疗组中,死亡率为零。发生并发症5例(8.9%):1例因肠系膜上动脉夹层导致亚急性肠缺血,2例动脉瘤再灌注,1例支架血栓形成,1例大量脾血肿。69例(55.2%)病例选择手术治疗,其中24例行VAA切除术,45例行动脉重建术。20例(29%)在急诊情况下进行了开放手术。在手术组中,8例急诊患者(40%)术中死亡。择期手术干预后的死亡率为零。术后并发症为4例移植血管晚期血栓形成(5.8%):3例无症状,1例需要行脾切除术。

结论

关于VAA的治疗指征尚无总体共识。目前在急诊情况下,应将血管内介入方法视为首选,因为其侵入性较小、进入和控制出血更快;这解释了介入治疗比开放手术死亡率更低的原因。血管内介入方法对VAA的择期修复有效,但在相当数量的患者中可能会发生与手术相关的并发症。鉴于死亡率相当且与手术相关的并发症发生率较低,手术方法在VAA的择期治疗中仍有空间,特别是对于手术风险低但不适合或难以采用血管内治疗方案的动脉瘤。VAA的大小、位置和形态、全身或局部合并症以及特定的解剖情况(如既往腹部手术)应决定治疗选择。

相似文献

1
Single-Center Experience in the Treatment of Visceral Artery Aneurysms.内脏动脉瘤治疗的单中心经验
Ann Vasc Surg. 2019 Oct;60:447-454. doi: 10.1016/j.avsg.2019.01.010. Epub 2019 Apr 19.
2
Endovascular Treatment of Visceral Artery Aneurysms and Pseudoaneurysms in 100 Patients: Covered Stenting vs Transcatheter Embolization.100 例内脏动脉动脉瘤和假性动脉瘤的血管内治疗:覆膜支架与经导管栓塞治疗比较。
J Endovasc Ther. 2017 Oct;24(5):709-717. doi: 10.1177/1526602817717715. Epub 2017 Jun 29.
3
The endovascular management of visceral artery aneurysms and pseudoaneurysms.内脏动脉瘤和假性动脉瘤的血管内治疗
J Vasc Surg. 2007 Feb;45(2):276-83; discussion 283. doi: 10.1016/j.jvs.2006.10.049.
4
Endovascular treatment of visceral artery aneurysms with Cardiatis multilayer flow modulator: preliminary results at six-month follow-up.使用Cardiatis多层血流调节器对内脏动脉瘤进行血管内治疗:六个月随访的初步结果。
J Cardiovasc Surg (Torino). 2011 Jun;52(3):311-21.
5
Is open repair still the gold standard in visceral artery aneurysm management?开放修复术仍是内脏动脉瘤治疗的金标准吗?
Ann Vasc Surg. 2011 Oct;25(7):936-46. doi: 10.1016/j.avsg.2011.03.006. Epub 2011 May 28.
6
Management of true visceral artery aneurysms in 31 cases.31例真性内脏动脉瘤的治疗
J Visc Surg. 2016 Nov;153(5):347-352. doi: 10.1016/j.jviscsurg.2016.03.008. Epub 2016 Jun 17.
7
Rupture Risk and Etiology of Visceral Artery Aneurysms and Pseudoaneurysms: A Single-Center Experience.内脏动脉瘤和假性动脉瘤的破裂风险及病因:单中心经验
Vasc Endovascular Surg. 2016 Jan;50(1):10-5. doi: 10.1177/1538574415627868.
8
Endovascular Repair of 40 Visceral Artery Aneurysms and Pseudoaneurysms with the Viabahn Stent-Graft: Technical Aspects, Clinical Outcome and Mid-Term Patency.使用Viabahn覆膜支架对40例内脏动脉瘤和假性动脉瘤进行血管内修复:技术要点、临床结果及中期通畅率
Cardiovasc Intervent Radiol. 2018 Mar;41(3):385-397. doi: 10.1007/s00270-017-1844-5. Epub 2017 Nov 21.
9
Initial experience with the E-ventus® stent-graft for endovascular treatment of visceral artery aneurysms.用于内脏动脉瘤血管内治疗的E-ventus®覆膜支架的初步经验。
J Cardiovasc Surg (Torino). 2018 Apr;59(2):225-231. doi: 10.23736/S0021-9509.17.09986-4. Epub 2017 May 26.
10
Visceral artery aneurysms: series of 17 cases treated in a single center.内脏动脉瘤:单中心治疗的17例病例系列
Int Angiol. 2010 Feb;29(1):30-6.

引用本文的文献

1
Imaging modalities used in follow-up after coil embolization of splenic artery aneurysm - a systematic review.脾动脉动脉瘤弹簧圈栓塞术后随访中使用的成像方式——一项系统评价
Pol J Radiol. 2025 May 13;90:e224-e233. doi: 10.5114/pjr/203730. eCollection 2025.
2
The safety and efficacy of transarterial embolization with detachable coils for complex visceral artery aneurysm.可脱性弹簧圈经动脉栓塞治疗复杂内脏动脉瘤的安全性和有效性。
Sci Rep. 2025 Jul 1;15(1):20786. doi: 10.1038/s41598-025-06917-7.
3
In Vitro Evaluation of Hydrogel Coils Combined with Liquid Embolic and Sclerosing Agents for Endovascular Embolization.
水凝胶弹簧圈联合液体栓塞剂和硬化剂用于血管内栓塞的体外评估
Cardiovasc Intervent Radiol. 2025 Jun 17. doi: 10.1007/s00270-025-04096-6.
4
Staged intervention in a patient with concomitant giant abdominal aortic aneurysm and hepatic artery.伴有巨大腹主动脉瘤和肝动脉的患者的分期干预。
J Int Med Res. 2025 Mar;53(3):3000605251325165. doi: 10.1177/03000605251325165. Epub 2025 Mar 13.
5
Comparative Efficacy and Safety of Self-Expandable vs. Balloon-Expandable Stent Grafts in Visceral Artery Aneurysm Management.自膨式与球囊扩张式覆膜支架治疗内脏动脉瘤的疗效及安全性比较
Diagnostics (Basel). 2024 Aug 5;14(15):1695. doi: 10.3390/diagnostics14151695.
6
Crush technique for percutaneous management of bifurcation of renal artery aneurysms.经皮处理肾动脉动脉瘤分叉处的挤压技术
Postepy Kardiol Interwencyjnej. 2024 Jun;20(2):217-220. doi: 10.5114/aic.2024.140183. Epub 2024 May 31.
7
CIRSE Standards of Practice for the Endovascular Treatment of Visceral and Renal Artery Aneurysms and Pseudoaneurysms.经导管血管内治疗内脏和肾动脉动脉瘤及假性动脉瘤的 CIRSE 实践标准。
Cardiovasc Intervent Radiol. 2024 Jan;47(1):26-35. doi: 10.1007/s00270-023-03620-w. Epub 2023 Nov 29.
8
Superior mesenteric artery aneurysm endovascular repair.肠系膜上动脉动脉瘤的血管内修复术。
J Vasc Surg Cases Innov Tech. 2023 May 23;9(3):101227. doi: 10.1016/j.jvscit.2023.101227. eCollection 2023 Sep.
9
Endovascular and Open Surgical Treatment of Ruptured Splenic Artery Aneurysms: A Case Report and a Systematic Literature Review.破裂性脾动脉瘤的血管内治疗与开放手术治疗:一例报告及系统文献综述
J Clin Med. 2023 Sep 20;12(18):6085. doi: 10.3390/jcm12186085.
10
Technical considerations of endovascular management of true visceral artery aneurysms.真性内脏动脉瘤血管内治疗的技术考量
CVIR Endovasc. 2023 Jun 7;6(1):31. doi: 10.1186/s42155-023-00368-9.